Cargando…
Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines
The cumulative impact of chronic inflammation in patients with inflammatory bowel diseases predisposes to the development of inflammatory bowel disease-associated colorectal cancer [IBD-CRC]. Inflammation can induce mutagenesis, and the relapsing–remitting nature of this inflammation, together with...
Autores principales: | Porter, Ross J, Arends, Mark J, Churchhouse, Antonia M D, Din, Shahida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684457/ https://www.ncbi.nlm.nih.gov/pubmed/34111282 http://dx.doi.org/10.1093/ecco-jcc/jjab102 |
Ejemplares similares
-
QuPath Algorithm Accurately Identifies MLH1-Deficient Inflammatory Bowel Disease-Associated Colorectal Cancers in a Tissue Microarray
por: Porter, Ross J., et al.
Publicado: (2023) -
c-MET immunohistochemical expression in sporadic and inflammatory bowel disease associated lesions
por: Halliday, Grant, et al.
Publicado: (2022) -
British Society of Gastroenterology interim framework for addressing the COVID-19-related backlog in inflammatory bowel disease colorectal cancer surveillance
por: Churchhouse, Antonia MD, et al.
Publicado: (2023) -
Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome
por: Porter, Chad K, et al.
Publicado: (2012) -
Emerging Mechanisms of Innate Immunity and Their Translational Potential in Inflammatory Bowel Disease
por: Corridoni, Daniele, et al.
Publicado: (2018)